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Natural killer (NK) cells play critical roles defending
against tumors and pathogens. We show that mice
lacking both transcription factors Eomesodermin
(Eomes) and T-bet failed to develop NK cells. Devel-
opmental stability of immature NK cells constitutively
expressing the death ligand TRAIL depended on
T-bet. Conversely, maturation characterized by loss
of constitutive TRAIL expression and induction of
Ly49 receptor diversity and integrin CD49b (DX5+)
required Eomes. Mature NK cells from which Eomes
was deleted reverted to phenotypic immaturity if
T-bet was present or downregulated NK lineage
antigens if T-bet was absent, despite retaining
expression of Ly49 receptors. Fetal and adult hepatic
hematopoiesis restricted Eomes expression and
limited NK development to the T-bet-dependent,
immature stage, whereas medullary hematopoiesis
permitted Eomes-dependent NK maturation in adult
mice. These findings reveal two sequential, geneti-
cally separable checkpoints of NK cell maturation,
the progression of which is metered largely by the
anatomic localization of hematopoiesis.
INTRODUCTION
NK cells derive from hematopoietic progenitors. A precursor that
lacks expression of NK antigens but expresses CD122 (IL-2Rb
and IL-15Rb) is believed to be committed to the NK lineage
and restricted from other blood cell fates (Rosmaraki et al.,
2001). NK precursors generate NK antigen-bearing (NK1.1+
NKp46+) NK cells that can undergo further phenotypic matura-
tion and express the integrins CD49b (DX5+) and CD11b (Chios-
sone et al., 2009; Kim et al., 2002; Walzer et al., 2007). Mature,
DX5+ NK cells express a diverse repertoire of Ly49 family recep-
tors, responsible for educating NK cells to self-MHC and for
enabling a broad specificity against microbial components
(Kim et al., 2002, 2005; Orr and Lanier, 2010). Development of
adult murine NK cells is thought to take place predominantly inthe bone marrow, though a variety of other tissues in mice and
humans, such as the liver, lymph node, and thymus,may support
NK cell development (Di Santo, 2006; Freud and Caligiuri, 2006;
Luther et al., 2011; Takeda et al., 2005; Vosshenrich et al., 2006).
The transcription factors ID2, TOX, and E4BP4 (Nfil3) are
thought to specify the earliest stages of NK cell development
(Aliahmad et al., 2010; Boos et al., 2007; Gascoyne et al.,
2009; Kamizono et al., 2009). Other transcription factors,
including Blimp-1, Ets-1, GATA-3, IRF-2, MEF, and PU.1, play
specific roles at distinct stages of NK cell development and
maturation (Barton et al., 1998; Colucci et al., 2001; Kallies
et al., 2011; Lacorazza et al., 2002; Lohoff et al., 2000; Samson
et al., 2003). The precise hierarchy of transcription factors gov-
erning NK cell maturation, however, is incompletely understood.
The highly homologous T-box transcription factors Eomeso-
dermin (Eomes) and T-bet direct fate and function in cytotoxic
lymphocytes. Eomes and T-bet redundantly regulate differentia-
tion of CD8+ effector T cells (Intlekofer et al., 2005, 2008; Pearce
et al., 2003). Eomes and T-bet also appear to have nonredundant
functions in specifying the fate of CD8+ T cells (Banerjee et al.,
2010; Intlekofer et al., 2007). It has been suggested that some
aspects of terminal NK cell maturation are dependent on T-bet
(Jenne et al., 2009; Townsend et al., 2004). We now report an
additional role for T-bet in stabilizing the immature NK cell fate.
The consequence of complete deletion of Eomes on NK cell
development had not yet been determined. We show that matu-
ration of NK cells to the DX5+ stage characterized by acquisition
of a diverse repertoire of activating and inhibitory Ly49 family
receptors is dependent on Eomes. Deletion of Eomes from
mature NK cells caused reversion to a more immature state.
Loss of both T-bet and Eomes from mature NK cells resulted
in loss of classical NK antigens. Progenitors lacking both Eomes
and T-bet could not support NK lineage development. Our data
support a model in which expression and function of T-bet and
Eomes define key, genetically separable molecular checkpoints
of NK cell maturation.
RESULTS
Eomes Is Required for NK Cell Maturation
We first examined the expression of Eomes protein at the single-
cell level in murine NK cells. The majority of NK cells expressedImmunity 36, 55–67, January 27, 2012 ª2012 Elsevier Inc. 55
Figure 1. Eomes Required for Maturation of NK Cells
(A) NK immaturity marker TRAIL correlates with absence of Eomes, and maturity marker DX5 correlates with presence of Eomes in wild-type (WT) splenic and
hepatic NK cells. Plots represent CD3εCD19Gr-1 NK1.1+NKp46+CD122+ cells (NK cells). Data are representative of at least five experiments.
Immunity
T-bet and Eomes Direct NK Cell Development
56 Immunity 36, 55–67, January 27, 2012 ª2012 Elsevier Inc.
Immunity
T-bet and Eomes Direct NK Cell DevelopmentEomes (Eomes+), but we detected aminor population of Eomes
NKcells in each organ examined (Figure 1A; Figure S1A available
online). The Eomes population was most enriched in the liver.
A subset of less mature NK cells that express the death ligand
TRAIL and lack CD49b are present in neonates and preferentially
reside in the adult liver (Kim et al., 2002; Takeda et al., 2005).
Eomes cells were characterized by TRAIL expression, whereas
Eomes+ cells expressed CD49b (DX5+) (Figure 1A). Eomes and
Eomes+ NK cells also expressed different repertoires of homing
receptors, consistent with their disparate anatomic localization.
Eomes NK cells expressed Integrin av and the chemokine re-
ceptors CXCR3 and CXCR6 at greater levels relative to Eomes+
NK cells (Figure 1B). Eomes NK cells expressed substantially
lower levels of the S1P receptors S1P1 and S1P5 than did
Eomes+ NK cells (Figure 1C). Eomes NK cells also underwent
less steady-state proliferation in vivo compared to Eomes+ NK
cells (Figure S1B).
To understand the requirements for Eomes in development
and homeostasis of NK cells, we analyzed mice harboring floxed
alleles of Eomes (Intlekofer et al., 2008) and expressing hemato-
poietic-specific Cre recombinase under control of Vav regulatory
elements (Stadtfeld and Graf, 2005). Eomesflox/floxVav-Cre+mice
had substantial reduction of NK cells in spleen and blood (Fig-
ures 1D and S1C). We observed a more modest reduction in
the numbers of NK cells in liver, lymph node, and bone marrow
of Eomesflox/floxVav-Cre+ mice. Despite the differences in NK
cell number, total cellularity of NK-containing organs in wild-
type and Eomesflox/floxVav-Cre+ mice were similar (Figure S1D).
The phenotype of NK cells from Eomesflox/floxVav-Cre+ mice
approximated that of Eomes NK cells from wild-type mice, ex-
pressing TRAIL but lacking CD49b (DX5) (Figures 1E and S1E).
The requirement for Eomes to develop DX5+ NK cells appeared
to be cell intrinsic. In wild-type plus Eomesflox/floxVav-Cre+mixed
bonemarrow chimeras, we observed that Eomesflox/floxVav-Cre+
marrow contributed inefficiently to the NK populations in the
blood, spleen, and bone marrow, which were composed pre-
dominantly of mature, DX5+ NK cells (Figures S1G and S1H). In
the liver, however, Eomesflox/floxVav-Cre+ marrow competitively
contributed to the TRAIL+ NK pool. The limited contribution of
Eomes-deficient marrow to the steady-state adult NK cell
compartment is consistent with prior suggestions that the major
proliferative burst in NK cell maturation occurs at the DX5+ stage
and that TRAIL+DX5 NK cells represent a minor subset in adult
mice (Kim et al., 2002; Takeda et al., 2005).(B) Integrin av, CXCR3, and CXCR6 are expressed predominantly by DX5
NK cells
were also present at low frequency in spleen and bone marrow (data not shown).
(Matloubian et al., 2000). Data are representative of three to five experiments.
(C) TRAIL+ NK cells express low amounts of S1pr1 (encoding S1P1) and S1pr5 (e
representative of two experiments.
(D) Eomesflox/floxVav-Cre+ mice are deficient in percentage and absolute numbers
‘‘Lin’’ denotes staining with anti-CD3, -CD19, -Gr-1, and -Ter119. Error bars indi
(E and F) Eomesflox/floxVav-Cre+ and wild-type Eomes NK cells express markers
of maturation markers TRAIL and DX5 (E) and Ly49 receptors (F) in Eomesflox/floxV
representative of three to five experiments.
(G) Expression of maturity markers CD27 and CD11b on hepatic Eomesflox/floxVav
three experiments.
(H) Kinetic analysis of NK cell maturation (Eomes expression) in mice of indicat
experiments.
(I) Analysis of maturity markers TRAIL and DX5 in adult medullary NK cells of the
See also Figure S1.DX5+ NK cells express a full complement of Ly49 family recep-
tors and can express the integrin CD11b (Kim et al., 2002).
Compared to Eomes+ NK cells, Eomesflox/floxVav-Cre+ and
wild-type Eomes NK cells exhibited a limited repertoire of
Ly49 receptors, expressing Ly49A, Ly49D, Ly49G2, and Ly49H
at markedly reduced frequencies (Figures 1F and S1F).
Eomesflox/floxVav-Cre+, wild-typeEomes, andwild-typeEomes+
NK cells did, however, express Ly49C and/or Ly49I at similar
frequencies. Few Eomesflox/floxVav-Cre+ and wild-type Eomes
NK cells expressed high levels of CD11b, whereas Eomes+ NK
cells were predominantly CD11bhi (Figure 1G). Thus, expression
of Eomes appears to demarcate two subsets of adult NK cells:
less mature, EomesTRAIL+ NK cells and more mature, Eomes+
DX5+NKcells. Eomes seemsessential forNKcells tomaturepast
the TRAIL+ stage and become DX5+ with a diverse repertoire of
Ly49 receptors.
Expression of Eomes Bisects Ontogenic and Adult NK
Cell Maturation
Fetal and neonatal NK cells lackmarkers of maturity and express
limited Ly49 receptor repertoires (Kubota et al., 1999; Takeda
et al., 2005), somewhat akin to NK cells in adult Eomesflox/flox
Vav-Cre+ mice. We found that NK cells from neonatal wild-type
mice have minimal expression of Eomes (Figure 1H). Postnatal
NK cells in the spleen initiated Eomes expression earlier and
more efficiently than did hepatic NK cells. The delayed onset
and anatomic bias of Eomes expression is consistent with the
prior suggestion that DX5+ NK maturation becomes evident
postnatally and preferentially outside the liver (Takeda et al.,
2005).Whether hepatic signals restrict Eomes or whether signals
present in other sites promote Eomes expression remains to be
determined.
Expression of Eomes by postnatal NK cells corresponds to the
ontogenic shift in hematopoiesis from the liver to thebonemarrow
(Keller et al., 1999). Whether adult medullary hematopoiesis
possesses anEomesTRAIL+ intermediate stageprior tomatura-
tion of Eomes+DX5+ NK cells was not known. Adult NK develop-
ment is seemingly characterized by an immature CD27loCD11blo
NK1.1+NKp46+ cell giving rise to a CD27hiCD11bloNK1.1+
NKp46+ cell, which can mature further and upregulate CD11b
(Chiossone et al., 2009; Kim et al., 2002; Walzer et al., 2007).
We found that acquisition of TRAIL occurs at the earliest stage
of definitive NK cell development, as shown by the fact that
the majority of medullary CD27loCD11bloNK1.1+NKp46+ cells. Plots represent hepatic NK cells. Integrin av
+CXCR3+CXCR6+TRAIL+ NK cells
‘‘CXCR6’’ represents detection of CXCL16-Fc, which binds to surface CXCR6
ncoding S1P5) compared to DX5
+ NK cells as assessed by qRT-PCR. Data are
of NK cells. Data are representative of at least five independent experiments.
cate standard deviation. *p < 0.05; **p < 0.001.
of immaturity, whereas Eomes+ NK cells express markers of maturity. Analysis
av-Cre+, wild-type Eomes, and wild-type Eomes+ hepatic NK cells. Data are
-Cre+ and wild-type Eomes and Eomes+ NK cells. Data are representative of
ed ages. Day 0 (d0) denotes the day of birth. Data are representative of two
indicated states of maturity. Data are representative of three experiments.
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contains both TRAIL+ and DX5+ NK cells, consistent with prior
studies suggesting that NK cells become DX5+ prior to express-
ing CD11b in the bone marrow (Kim et al., 2002). Reciprocal
expression of TRAIL and Eomes was also a consistent feature
of medullary NK cell maturation (Figure 1I). Expression of Eomes
and loss of TRAIL thus defines both the ontogenic appearance of
mature NK cells and the acquisition of mature NK markers by
developing adult NK cells.
Eomes– NK Cells Can Give Rise to Eomes+ NK Cells
Eomes appears to direct NK maturation past the immature,
TRAIL+Integrin av
+CD11blo state to the mature, DX5+CD11bhi
state. Whether Eomes NK cells are the direct predecessors of
Eomes+ NK cells has not been determined. Analyses of NK cell
development in bone marrow and cell transfer experiments
with defined intermediates are compatible with a model wherein
TRAIL+Integrin av
+ NK cells may give rise to DX5+ NK cells
(Chiossone et al., 2009; Kim et al., 2002; Takeda et al., 2005).
To address whether TRAIL+ NK cells can upregulate Eomes
while maturing into DX5+ NK cells, we sorted hepatic TRAIL+
NK cells to 97% purity and transferred them into unirradiated,
immunodeficient Il2rg/Rag2/ mice, which lack NK cells
and other lymphocytes.
One (Figure 2A) or two (Figure 2B) weeks after transfer, the
livers, spleens, and bone marrow of recipients were analyzed
for presence of NK cells. Transferred immature, TRAIL+ NK cells
underwent in vivo maturation characterized by repression of
TRAIL as well as induction of CD49b (DX5+), Eomes, and Ly49
receptors (Figures 2A and 2B). NK cell maturation and induction
of Eomeswas restricted in liver, promoted in spleen, and favored
most in bone marrow. Conversion of TRAIL+ NK cells into DX5+
Eomes+ NK cells in immunodeficient mice is consistent with prior
findings that purified neonatal or adult TRAIL+ NK cells can
downregulate TRAIL and induce CD49b (DX5+) when transferred
into sublethally irradiated, immunocompetent recipients (Takeda
et al., 2005). We observed analogous, yet less efficient, conver-
sion of EomesTRAIL+ to Eomes+DX5+Ly49+ cells in immuno-
competent recipients (Figure S2A). Purified, hepatic DX5+
NK cells transferred to Il2rg/Rag2/ mice remained DX5+,
Eomes+, and Ly49+ after adoptive transfer (Figures 2A and 2B),
consistent with prior experiments showing stability of CD49b
expression (Takeda et al., 2005). Acquisition of Eomes expres-
sion in the mature, DX5+ stage of NK cell development thus
appears to be a stable event.
To assess whether Eomes is essential for the conversion of
TRAIL+ to DX5+ NK cells, we purified TRAIL+ NK cells from
Eomesflox/floxVav-Cre+ donor mice and transferred the cells to
Il2rg/Rag2/ recipients. In contrast to wild-type TRAIL+
donor NK cells, Eomesflox/floxVav-Cre+ TRAIL+ donor NK cells
neither downregulated TRAIL efficiently nor stained brightly
with DX5 (Figure 2C). After transfer, Eomesflox/floxVav-Cre+
TRAIL+ donor cells did exhibit Ly49D, Ly49G2, and/or Ly49H
expression at a diminished but detectable frequency relative to
wild-type donor cells, which may be consistent with prior sug-
gestions that Ly49 receptor acquisition can precede CD49b
induction and cellular expansion in medullary NK cell develop-
ment (Kim et al., 2002). Together, these data are consistent
with a model in which induction of Eomes is essential for imma-58 Immunity 36, 55–67, January 27, 2012 ª2012 Elsevier Inc.ture, TRAIL+ NK cells to become mature, DX5+ NK cells with
robust expression of diverse Ly49 receptors.
Because TRAIL is expressed by the least differentiated adult
NK cells in the bone marrow (Figure 1I), we tested whether
medullary TRAIL+ NK cells can give rise to mature, DX5+ NK
cells. TRAIL+ CD27loCD11blo and TRAIL+CD27hiCD11blo NK
cells were sorted from the bone marrow (at least 95% purity)
and adoptively transferred into Il2rg/Rag2/ mice. Trans-
ferred medullary TRAIL+ NK cells matured into TRAILEomes+
NK cells and did so to a greater extent in the spleens than in
the livers of recipient mice (Figure 2D). Additionally, immature,
TRAIL+ NK cells converted to mature NK cells as measured by
expression of CD27 and CD11b, consistent with previous adop-
tive transfer studies (Chiossone et al., 2009). These data support
a model in which medullary NK precursors give rise to cells that
express NK antigens and which are CD27loCD11blo and TRAIL+
Eomes. In the bone marrow environment, TRAIL+Eomes NK
cells readily undergo Eomes-dependent maturation to become
DX5+Eomes+ NK cells that progress through defined stages of
CD11b induction and subsequent CD27 repression. In contrast,
Eomes-dependent maturation by TRAIL+Eomes NK cells is
restricted in the hepatic environment.
Eomes Maintains Maturity of NK Cells
To investigate the role of Eomes in maintaining NK cells in the
mature state, we temporally deleted Eomes from mature NK
cells. Splenic NK cells with floxed alleles of Eomeswere isolated
and treated directly ex vivo with Crerecombinase fused to the
transduction domain of the HIV TAT protein (TAT-Cre) (Wadia
et al., 2004). Treated or sham-treated cells were adoptively
transferred into unirradiated Il2rg/Rag2/ mice. From recipi-
ents of sham-treated cells, we retrieved Eomes+DX5+ NK cells
that expressed diverse Ly49 receptors and EomesTRAIL+ NK
cells that displayed a paucity of Ly49 receptor expression
(Figures 3A and 3B). From recipients of TAT-Cre-treated cells,
we retrieved an additional population of Eomes cells that
expressed Ly49 receptors, which presumably represented
formerly mature, Eomes+DX5+ NK cells that underwent Cre-
mediated deletion of Eomes (Figures 3A and 3B). The stability
of all Ly49 family members examined in cells lacking Eomes
protein suggested thatmaintenance of Ly49 receptor expression
may not depend on Eomes, even though establishment of
a diverse Ly49 repertoire is Eomes dependent.
In contrast to the stability of Ly49 expression, we found that
temporal deletion of Eomes resulted in loss of other maturity
markers. A substantial proportion of Ly49+ NK cells that lost
expression of Eomes became TRAIL+ and DX5 in the liver,
spleen, and bone marrow of recipient mice (Figure 3B). We also
observed partial derepression of Integrin av and CXCR6 in
hepatic but not splenic Ly49+ NK cells after loss of Eomes (Fig-
ure S3). These findings suggest that Eomes directly or indirectly
represses the markers of immaturity TRAIL, Integrin av, and
CXCR6, while inducing the maturity marker CD49b (DX5+).
Eomes+DX5+ NK cells normally retain their TRAILDX5+ identity
(Figure 2), but loss of Eomes can cause mature cells to downre-
gulate CD49b (DX5) and upregulate TRAIL, despite maintaining
expression of Ly49 receptors (Figure 3B). The reversion in pheno-
typic attributes after temporal deletion of Eomes complements
the prior findings suggesting that EomesTRAIL+ NK cells can
Figure 2. Eomes– NK Cells Can Give Rise to Eomes+ NK Cells
(A) Highly purified, wild-type TRAIL+ or DX5+ donor NK cells were adoptively transferred into Il2rg/Rag2/ recipients. One week posttransfer, indicated organs
of recipient mice were harvested and donor NK cells were analyzed for expression of Eomes, Ly49 receptors, andmaturation markers TRAIL and DX5. This assay
reveals TRAIL+Eomes+ NK cells, which may represent a transient, intermediate stage that is ordinarily outpopulated by TRAILDX5+Eomes+ cells in intact adults.
(B) Two weeks posttransfer of wild-type TRAIL+ NK cells, donor NK cells were analyzed for indicated markers.
(C) Hepatic wild-type or Eomesflox/floxVav-Cre+TRAIL+ donor NK cells were adoptively transferred into Il2rg/Rag2/ recipients. Bone marrow of recipient mice
was harvested after 1 week and donor NK cells were analyzed for expression of indicated markers.
(D) Medullary TRAIL+ or DX5+ NK cells of indicated substages of maturity were adoptively transferred into Il2rg/Rag2/ recipients. Indicated organs of
recipient mice were harvested after 1 week, and donor NK cells were analyzed for expression of Eomes and maturation markers TRAIL, CD27, and CD11b. Data
are representative of three experiments.
See also Figure S2.
Immunity
T-bet and Eomes Direct NK Cell Developmentbe in vivo intermediates that give rise to mature, Eomes+DX5+
NK cells (Figure 2). Together, these experiments provide forward
and reverse evidence that acquisition of Eomes elaborates and
maintains mature attributes on the immature NK cell foundation.Stability of Neonatal and Adult Eomes– NK Cells
Depends on T-bet
To evaluate the role of T-bet in NK cell development, we com-
pared the phenotypes and patterns of T-box protein expressionImmunity 36, 55–67, January 27, 2012 ª2012 Elsevier Inc. 59
Figure 3. Eomes Required to Maintain Some Aspects of Mature
NK Cells
(A and B) Splenic NK cells with floxed alleles of Eomeswere purified and either
treated with TAT-Cre or sham-treated directly ex vivo. Donor cells were
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Tbx21/ mice contained predominantly NK cells expressing
CD49b (DX5+), a diverse Ly49 repertoire, and high levels of
Eomes (Figures 4A, 4B, and S4A–S4C). EomesTRAIL+ NK pop-
ulations were seemingly absent from Tbx21/ mice, while
TRAIL+ cells represented the predominant NK population of
Eomesflox/floxVav-Cre+ mice. T-bet was not required for expres-
sion of TRAIL itself, however, as shown by the fact that Tbx21/
NK cells readily induced TRAIL after in vitro stimulation (Fig-
ure S4D). Tbx21/ and Eomesflox/floxVav-Cre+ mice thus have
reciprocal maturational phenotypes: Tbx21/ mice lack imma-
ture (TRAIL+DX5) NK cells, whereas Eomesflox/floxVav-Cre+
mice lack mature (TRAILDX5+) NK cells.
T-bet is normally expressed in both Eomes and Eomes+ NK
cells (Figures 4B and S4A), which is consistent with roles for
T-bet in both immature and mature NK cell stages. In addition
to playing an essential role in development or maintenance
of the immature, EomesTRAIL+DX5 subset (Figures 4A,
4B, S4A, and S4B), T-bet controls repression of CD27 and
c-kit as well as induction of CD43 and KLRG1 in NK cells (Fig-
ure S4E), as has been previously suggested (Jenne et al.,
2009; Kallies et al., 2011; Townsend et al., 2004). Although
mature, DX5+ NK cells can develop without T-bet, the most
terminal stages of maturation are incomplete in the absence of
T-bet. By using wild-type plus Tbx21/ mixed bone marrow
chimeras, we found that the previously described requirement
for T-bet in repressing CD27 among mature NK cells was
predominantly cell intrinsic (Figures S4F and S4G). This finding
contrasts with the recent observation that T-bet-deficient NK
cellsmight be capable of repressingCD27 in awild-type environ-
ment (Soderquest et al., 2011), suggesting that the effect of
T-bet could also be partially cell extrinsic. We also observed
the newly described requirement for T-bet in development or
maintenance of the immature EomesTRAIL+DX5 NK popula-
tion to be cell intrinsic (Figures S4F and S4G).
T-bet appears required to develop or stabilize immature NK
cells, and immature NK cells are the predominant NK cells in
the perinatal period (Takeda et al., 2005). We therefore assessed
the NK compartment of neonatal T-bet-deficient mice. Tbx21/
neonates possessed substantially reduced NK cell numbers
relative to age-matched, wild-type control mice (Figures 4C
and 4D). The NK cells present in Tbx21/ neonates expressed
Eomes (Figure S4H). Expression of TRAIL on Eomes+ NK cells
of Tbx21/ neonates was higher than on wild-type Eomes+
NK cells, which suggests that DX5+ NK cells in adult Tbx21/
mice may transit through a TRAIL+ intermediate. In contrast to
the paucity of NK cells in neonatal Tbx21/ mice, tissues from
neonatal Eomesflox/floxVav-Cre+ mice contained comparable
numbers of NK cells to littermate controls (Figure S4I), consistenttransferred into Il2rg/Rag2/ recipients and analyzed 7–10 days later.
Expression of Ly49A, Ly49G2, Ly49H (A), and Ly49D (B) was stable in mature
NK cells fromwhich Eomes was temporally deleted. Data are representative of
at least two separate experiments.
(B) Derepression of TRAIL and downregulation of CD49b by mature NK cells
after temporal deletion of Eomes. Ly49D+ NK cells were analyzed for matu-
ration markers TRAIL and DX5 (bottom rows). Data are representative of five
experiments.
See also Figure S3.
Figure 4. T-bet Stabilizes Immature, Eomes– NK Cells and Either T-bet or Eomes Required for NK Lineage Marker Stability
(A and B) Expression of maturation markers TRAIL and DX5 (A), along with expression of T-bet and Eomes (B), in wild-type, Eomesflox/floxVav-Cre+, and Tbx21/
hepatic NK cells. Data representative of at least five experiments.
(C and D) T-bet-deficient neonates are deficient in NK cells.
(C) Developmental analysis of hepatic and splenic NK cell compartments in wild-type and Tbx21/mice of indicated ages. Day 0 (d0) denotes the day of birth.
Data are representative of at least five experiments.
(D) Quantification of absolute number of NK cells in wild-type and Tbx21/ neonatal mice, aged d0 to d2. Error bars indicate standard deviation. **p < 0.001;
***p < 0.0001.
(E) Acute loss of T-bet destabilizes TRAIL+ NK cells. Hepatic NK cells with floxed alleles of Tbx21 were purified and either treated with TAT-Cre or sham-treated
directly ex vivo. Donor cells were transferred into Il2rg/Rag2/ recipients and analyzed 7–10 days later. NK cells from livers of recipient mice were analyzed for
expression of Eomes and Ly49 receptors. Data are representative of two experiments.
(F) Absence of NK cells in indicated organs of mice doubly deficient in T-bet and Eomes. Data are representative of two experiments.
(G) Loss of NK lineage antigens after acute loss of Eomes in the setting of T-bet deficiency. Purified, Tbx21/Eomesflox/flox NK cells transferred to Il2rg/Rag2/
recipient mice in vivo (top) or cultured in 2,000 U/mL rIL-2 in vitro (bottom) after TAT-Cre or sham treatment. Organs of recipient mice were analyzed 1 week after
adoptive transfer. Cells cultured in IL-2 were analyzed after 5 days. Plots represent presently or formerly mature NK cells, based on purified starting population
and gating of CD3 (Ly49D+ and/or LyG2+) cells (gating shown in Figure S4M). CD3Ly49+ cells were analyzed for expression of Eomes and the NK lineage
antigens NK1.1 and NKp46. Data are representative of three in vitro and two in vivo experiments.
(H) Loss of DX5 and TRAIL staining in T-bet-deficient NK cells after temporal deletion of Eomes. CD3Ly49D+ cells as depicted in upper row of (G) were further
analyzed for staining of CD49b (DX5) and TRAIL.
See also Figure S4.
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NK cell development (Figure 1H).
To address whether stability of TRAIL+ NK cells depends on
T-bet, we temporally deleted T-bet by treating hepatic NK cellswith floxed alleles of Tbx21with TAT-Cre ex vivo and by transfer-
ring cells into Il2rg/Rag2/ mice. From recipients of sham-
treated cells, we recovered both immature, EomesTRAIL+ NK
cells and mature, Eomes+ NK cells (Figure 4E). From recipientsImmunity 36, 55–67, January 27, 2012 ª2012 Elsevier Inc. 61
Figure 5. Functional Analyses of NK Cells Lacking T-bet and Eomes
(A–C) Expression of effector genes and proteins by TRAIL+Eomes and DX5+Eomes+ NK cells.
(A) Levels of mRNA for genes encoding Eomes, Perforin, and Granzyme C were analyzed by qRT-PCR. Error bars indicate standard error of the mean (SEM).
(B) Expression of Granzyme B (Gzmb) by wild-type, unstimulated, hepatic Eomes and Eomes+ NK cells (far left), degranulation by wild-type hepatic Eomes and
Eomes+ NK cells after stimulation with PMA and iono for 4 hr in vitro (left middle), expression of IFN-g by wild-type hepatic Eomes and Eomes+ NK cells after
stimulation with rIL-12 and rIL-18 for 4 hr in vitro (right middle), and expression of TNF-a by wild-type hepatic Eomes and Eomes+ NK cells after stimulation with
PMA and iono for 4 hr in vitro (far right).
(C) Expression of Granzyme B (Gzmb) by wild-type, Eomesflox/floxVav-Cre+, and Tbx21/, unstimulated, hepatic NK cells (top) and expression of IFN-g by
wild-type, Eomesflox/floxVav-Cre+, and Tbx21/ hepatic Eomes and Eomes+ NK cells after stimulation with recombinant IL-12 and IL-18 for 4 hr in vitro (bottom).
(D–F) Response by wild-type, Tbx21/, and Eomesflox/floxVav-Cre+ NK cells 7 days after MCMV infection.
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NK cells that lost expression of T-bet (Figure S4J). TAT-Cre treat-
ment markedly diminished the presence of EomesTRAIL+ NK
cells while not seemingly affecting the recovery of mature,
Eomes+ NK cells (Figure 4E). Whether by maintaining its survival
or by curbing its progressive maturation, these findings suggest
that T-bet stabilizes the EomesTRAIL+ stage of NK cell develop-
ment. Accelerated maturation of EomesTRAIL+ NK cells to
Eomes+DX5+ NK cells after loss of T-bet might be possible owing
to the finding that NK cells from which T-bet was acutely (Fig-
ure S4J) or chronically (Figures 4B and S4A) deleted both ex-
hibited increased levelsof Eomesexpression. Thesedata support
a model in which neonatal and immature adult EomesTRAIL+
NK cells depend on T-bet for developmental stability.
T-bet or Eomes Is Required for an NK Lineage Cell to Be
Maintained
T-bet and Eomes seem to be required for stability or develop-
ment of sequential (or alternative) stages of NK cell maturation.
We intercrossed Eomesflox/floxVav-Cre+ mice with Tbx21/
mice to yield Tbx21/Eomesflox/floxVav-Cre+ animals, lacking
both Eomes and T-bet in the hematopoietic compartment. We
could not detect NK cells in any organ of Tbx21/Eomesflox/flox
Vav-Cre+ animals (Figure 4F), which is consistent with the hypo-
thetical addition of the two complementary, Tbx21/ and
Eomesflox/floxVav-Cre+ phenotypes (Figure 4A). Despite absence
of NK antigen-expressing NK cells, we found that NK antigen-
negative, CD122hi precursors of NK cells were present in
Tbx21/Eomesflox/floxVav-Cre+ mice (Figure S4K). The pres-
ence of NK precursors in Tbx21/Eomesflox/floxVav-Cre+
animals is consistent with the low levels of T-bet and Eomes nor-
mally expressed in wild-type precursors (Figure S4L).
We next temporally deleted floxed alleles of Eomes from
mature NK cells already lacking T-bet and either adoptively
transferred them into immunodeficient mice or cultured them in
interleukin-2 in vitro. T-bet-deficient, mature NK cells that under-
went temporal deletion of Eomes maintained Ly49 receptor
expression but downregulated the NK antigens NK1.1 and
NKp46 (Figure 4G) as well as TRAIL and CD49b (DX5), the iden-
tifying markers of immaturity and maturity of NK cells, respec-
tively (Figure 4H). In contrast, T-bet-sufficient control cells from
which Eomes was deleted maintained NK-lineage identity
despite downregulating CD49b (DX5) and upregulating TRAIL.
Expression of CD122 on acutely double-deficient NK cells was
minimally affected (Figure S4M). These data are consistent with
a model in which T-bet and Eomes are dispensable for develop-
ment of CD122-expressing NK cell precursors but are essential
for stable development of NK antigen-expressing NK cells.
Effector Function of NK Cells in the Absence of T-box
Factors
Prior analyses suggest that both TRAIL+ and DX5+ NK cells can
lyse YAC-1 target cells and produce interferon-gamma (IFN-g)(D) Analysis of Ly49D and Ly49H expression by splenic (top) and hepatic (bottom
(E) Expression of maturation and activation markers KLRG1, CD11b, TRAIL, and
(F) More highly activated, hepatic NK cells from MCMV-infected Eomesflox/floxVav
least two experiments.
See also Figure S5.when stimulated in vitro (Takeda et al., 2005). T-bet-deficient
mature NK cells are thought to possess lytic and cytokine-
secreting function (Townsend et al., 2004). We found that
EomesTRAIL+ and Eomes+DX5+ NK subsets from wild-type
mice, as well as Tbx21/ NK cells, Eomesflox/floxVav-Cre+ NK
cells, and T-bet-deficient NK cells with temporally deleted alleles
of Eomes were all poised for substantial effector gene expres-
sion and function when challengedwith a variety of stimuli in vitro
and in vivo (Figures 5 and S5). Mature Eomes+DX5+ NK cells
expressed modestly more Perforin (Prf1) mRNA than immature
EomesTRAIL+ NK cells (Figures 5A and S5A), consistent
with a role for Eomes in inducing Prf1 (Cruz-Guilloty et al.,
2009; Intlekofer et al., 2005; Pearce et al., 2003). Immature
EomesTRAIL+ NK cells expressed increased Granzyme C
(Gzmc) mRNA (Figure 5A) and elevated levels of Granzyme B
(GzmB) and TNF-a protein, consistent with the phenotype
of Eomesflox/floxVav-Cre+ NK cells (Figures 5B, 5C, S5C,
and S5D). Immature and mature wild-type NK cells, as well as
Tbx21/ NK cells, Eomesflox/floxVav-Cre+ NK cells, and T-bet-
deficient NK cells with temporally deleted alleles of Eomes,
were all able to degranulate and express IFN-g (Figures 5B,
5C, and S5B–S5D).
We also found that Eomesflox/floxVav-Cre+ and Tbx21/ mice
were able to clear target cells missing self in vivo (data not
shown), which is consistent with findings that Eomes and
Eomes+ NK cells expressed NKG2A (Figure S5E) and Ly49C
and/or Ly49I (Figure 1F), which bind MHC class I ligands in
C57BL/6 mice (Brennan et al., 1996a, 1996b; Liu et al., 2000)
and arm or license NK cells to kill targets (Kim et al., 2005; Raulet
and Vance, 2006; Vance et al., 1998). NK cells, thus, appear to
acquire substantial effector function once beyond the NK
progenitor stage. Preservation of functions in NK cells temporally
deficient in both T-box transcription factors suggest that effector
gene expression may be epigenetically stable or regulated by
factors other than T-bet and Eomes (Barton et al., 1998; Lacor-
azza et al., 2002; Lohoff et al., 2000; Samson et al., 2003).
Infection with murine cytomegalovirus (MCMV) results in
activation and expansion of NK cells in mice (Arase et al.,
2002; Dokun et al., 2001; Lee et al., 2001). We tested whether
infection with MCMV would induce Eomesflox/floxVav-Cre+
NK cells to express markers of maturity and activation,
CD49b (DX5+), CD11b, and KLRG1 (Robbins et al., 2004; Zafir-
ova et al., 2009). MCMV infection induced expansion of
MCMV-specific Ly49H+ NK cells in wild-type, Tbx21/, and
Eomesflox/floxVav-Cre+ (Figure 5D) mice. Ly49H+ NK cells from
infected mice of each genotype expressed high levels of
CD11b and KLRG1, although the frequency was highest in cells
from wild-type and lowest in cells from Eomesflox/floxVav-Cre+
mice (Figure 5E). The majority of the Ly49H+ NK cells in
MCMV-infected Eomesflox/floxVav-Cre+ mice did not repress
TRAIL or express CD49b (DX5+). Those Ly49H+ Eomesflox/flox
Vav-Cre+ NK cells that were CD11bhi and KLRG1hi (and thus
appeared most activated) were more likely to be DX5+ and) NK cells from MCMV-infected mice of indicated genotypes.
DX5 by hepatic Ly49H+ and Ly49H NK cells of indicated genotypes.
-Cre+ mice can induce CD49b and repress TRAIL. All data representative of at
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this represents stable, Eomes-independent acquisition of a
mature phenotype (Figure 5F). The failure to detect Ly49D on
Eomesflox/floxVav-Cre+ NK cells suggests that infection with
MCMV does not completely bypass the requirement for Eomes
in NK cell maturation.
DISCUSSION
Developing NK cells are believed to derive from lymphoid
progenitors (Spits and Di Santo, 2011). Restriction of B cell
potential and commitment to the innate lymphoid lineage
appears to be mediated by ID2 (Boos et al., 2007; Carotta
et al., 2011). ID2-expressing NK precursors may give rise to
canonical NK cells in an E4BP4- and TOX-dependent fashion
(Aliahmad et al., 2010; Carotta et al., 2011; Gascoyne et al.,
2009; Kamizono et al., 2009). Previous studies have elucidated
various phenotypic stages of NK maturation (Chiossone et al.,
2009; Kim et al., 2002; Takeda et al., 2005), but the molecular
events that control passage through these stages are not fully
understood.
We found that NK cell development is profoundly impaired in
the absence of both Eomes and T-bet. The phenotypes of
Tbx21/ mice and Eomesflox/floxVav-Cre+ mice were not, how-
ever, identical. The most striking defect in each case was the
loss of a distinct and nonoverlapping phenotypic subset
from that lacking in the other T-box factor-deficient mouse.
The Tbx21/Eomesflox/floxVav-Cre+ phenotype approximated
the addition of Tbx21/ and Eomesflox/floxVav-Cre+ phenotypes.
Eomes or T-bet may also be essential to maintain the lineage
identity of NK cells as shown by the fact that temporal loss of
both T-box factors seems to abrogate expression of NK1.1
and NKp46 in cells that were formerly mature NK cells.
Our data support a model wherein NK precursors may up-
regulate T-bet and transit to an immature, NK1.1+NKp46+
EomesDX5TRAIL+T-bet+ state. This developmental sequence
seems to be the predominant, if not exclusive, manner of NK
cell development in embryogenesis and in neonates, when
hematopoiesis is predominantly occurring in the liver (Keller
et al., 1999). Immature, EomesDX5TRAIL+T-bet+ NK cells
persist in adulthood, predominantly as a stable lineage in the liver
and as a more mercurial intermediate that transits to a mature
stage in the bone marrow (Kim et al., 2002; Takeda et al.,
2005). Importantly, the immature, DX5TRAIL+ NK cell identity
appears strictly dependent on T-bet but not Eomes for its
stability.
In adult hematopoiesis, which occurs predominantly in
the bone marrow, NK precursors appear to give rise to a
similarly immature-appearing, NK1.1+NKp46+CD27loCD11blo
EomesDX5TRAIL+T-bet+ stage (Chiossone et al., 2009; Kim
et al., 2002; Walzer et al., 2007). In contrast to hepatic hemato-
poiesis, the bone marrow environment appears permissive for
EomesTRAIL+ NK cell intermediates to acquire expression of
Eomes, yielding subsequent stages of NK cell maturation that
we now show are strictly dependent on the function of Eomes.
In the adult, reciprocal TRAIL and Eomes expression appears
to bisect bone marrow NK cell development akin to the onto-
genic shift in NK cell development observed postnatally. Rela-
tively immature CD27hiCD11blo NK cells (Chiossone et al.,64 Immunity 36, 55–67, January 27, 2012 ª2012 Elsevier Inc.2009) contain both immature (TRAIL+Eomes) and mature
(TRAILEomes+) NK cells. The apparent overlap of the Tbx21/
and Eomesflox/floxVav-Cre+ phenotypes in the CD27hiCD11blo
medullary stage is resolvable into nonoverlapping TRAIL+
CD27hiCD11blo and DX5+CD27hiCD11blo substages, based on
the findings that bone marrow from Tbx21/ and Eomesflox/flox
Vav-Cre+ mice lacks TRAIL+ and DX5+ NK cells, respectively.
The Eomes-dependent phenotypic properties of mature,
Eomes+DX5+TRAILT-bet+ NK cells, including repression of
TRAIL and expression of CD49b (DX5+), also require ongoing
Eomes activity to retain this identity. One of the unresolved
features of the present model is whether all mature, DX5+TRAIL
NK cells transit through a DX5TRAIL+ intermediate stage or
whether the Eomes-dependent DX5+ state is an alternative
lineage to the T-bet-dependent TRAIL+ state.
Despite TRAIL reinduction and loss of CD49b, the Ly49 reper-
toire appears to remain fixed after the loss of Eomes. Chromatin
modifications and DNA methylation changes may mark the
activity of Ly49 family members (Rouhi et al., 2006, 2007).
The apparent heritability of Ly49 maintenance, together with
the detection of Ly49 family expression after proliferation of
Eomesflox/floxVav-Cre+TRAIL+ NK cells in lymphopenic mice
and the prior suggestion that Ly49 acquisition precedes
CD49b expression and cell division in the bone marrow (Kim
et al., 2002) suggest an epigenetic basis for the action of Eomes
at the Ly49 locus. Ly49 genes may be poised for induction prior
to acquiring Eomes, but Eomes-dependent modifications, direct
or indirect, may be essential to establish heritable Ly49 gene
activity that can persist after loss of Eomes.
Why the fetal and neonatal NK repertoire consists predomi-
nantly of immature NK cells remains unresolved. The paucity of
Ly49 receptors on early neonatal NK cells (Kubota et al., 1999)
can now be linked to the restriction on Eomes induction in the
hepatic milieu. Future experiments involving enforced Eomes
expression within the immature, TRAIL+ stage will, thus, be
informative for determining whether there is an undesirable
consequence of maturation of the Ly49 repertoire in early devel-
opment. Activation or tolerization of fetal NK cells through expo-
sure to maternal components missing paternal MHC molecules
might be reasons that repertoire selection of NK cells is delayed
until after birth (Kumar et al., 1997; Tripathy et al., 2008). Humans
and mice are highly susceptible to devastating, often fatal infec-
tion with herpes viruses in the perinatal period, owing partly to
deficiency in NK cell-mediated antiviral responses (Anzivino
et al., 2009; Bukowski et al., 1985). If more mature or more abun-
dant NK cells are not catastrophic to fetus or mother, future
studies may be directed toward mobilizing NK cells to clear viral
pathogens in utero and in newborns.
The medullary and splenic microenvironments seem to drive
NK expression of Eomes, whereas the liver appears nonper-
missive for Eomes induction. The microenvironmental signals
upstream of Eomes induction, however, remain to be elucidated.
We observed derepression of Eomes in steady-state T-bet-defi-
cient NK cells and in NK cells that acutely lost T-bet. It is possible
that T-bet directly or indirectly plays a role in repressing expres-
sion of Eomes. Lowest amounts of T-bet appear to be found in
NK cells of the bone marrow, which may be mechanistically
linked to the observation that TRAIL+ NK cells acquire Eomes
most readily in the bone marrow after adoptive transfer.
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repertoire of Ly49 receptors, including Ly49H, which is essential
to mediate resistance against MCMV infection (Arase et al.,
2002; Lee et al., 2001). Although Eomes+DX5+ NK cells are likely
to be essential for resistance to some infections, it remains to be
determined whether TRAIL+ NK cells serve unique functions in
other aspects of host defense. Apart from their obvious differ-
ences in Ly49 repertoire, TRAIL+ and DX5+ NK cells express
some similar but some dissimilar effector components. Future
studies will be directed toward determining whether TRAIL+
and DX5+ NK cells kill targets in the same manner, whether
both subsets are capable of memory responses, and whether
effector memory cell functions are dependent on T-bet, Eomes,
or both (Cooper et al., 2009; Paust et al., 2010; Sun et al., 2009).
The transcription factors Eomes and T-bet are highly homolo-
gous and have both redundant and nonredundant roles in CD8+
T cell differentiation and function (Banerjee et al., 2010; Gordon
et al., 2011; Intlekofer et al., 2005, 2007, 2008; Kinjyo et al., 2010;
Pearce et al., 2003;Weinreich et al., 2010). Their overlapping and
nonoverlapping target genes have not yet been completely
defined. The present study reveals that these two factors are
molecular determinants that control transit through unique NK
cell maturational checkpoints. Understanding how expression
of T-bet and Eomes is regulated and how they, in turn, regulate
distinct target genes should offer new avenues to customize
CD8+ T and NK cellular therapy against infection and cancer.
EXPERIMENTAL PROCEDURES
T-bet- and Eomes-Deficient Mice
Mice were housed in specific-pathogen-free conditions and used in accor-
dancewithUniversity of Pennsylvania Institutional Animal Care andUseGuide-
lines. C57BL/6 Eomesflox/flox, Tbx21/ (Intlekofer et al., 2005, 2008), and
Vav1-Cre+ (Stadtfeld and Graf, 2005) mice were bred to obtain Eomesflox/flox
Vav-Cre+ mice and Eomesflox/floxTbx21/Vav-Cre+ mice, used between 4
and 16 weeks of age.
Flow Cytometry
Livers were harvested by dissecting the inferior vena cava and aorta. Liver was
perfused thoroughly with ice-cold PBS + 2mMEDTA + 1% fetal bovine serum.
Once no visible blood remained, the liver was harvested, and liver lymphocytes
were obtained by mechanical dissociation of the liver and passage through
a 70 mm strainer. The liver was resuspended in 40% Percoll and underlaid
with 60% Percoll (GE Healthcare). Lymphocytes were isolated at the inter-
phase after centrifugation. Hepatic and other lymphocytes were stained with
LIVE/DEAD fixable dead cell stain kit (Invitrogen), prior to staining with anti-
bodies. Cells were analyzed on an LSR II coupled to FACSDiva software (BD
Biosciences) and data were analyzedwith FlowJo software (Treestar). Sources
ofmAbs are provided in the Supplemental Experimental Procedures. CXCL16-
Fc (Matloubian et al., 2000) was detected by a biotin-conjugated, anti-human
Fc antibody (Jackson Immunoresearch).
Mixed Bone Marrow Chimeras
Wild-type (CD45.1+) plus Eomesflox/floxVav-Cre+ (CD45.2+) or wild-
type (CD45.1+) plus Tbx21/ (CD45.2+) FACS-purified blood progenitors
(Lineagec-kithiSca-1hi) were used as donor cells. 1 3 103 donor cells were
injected i.v. into sublethally irradiated (450 rads) Il2rg/Rag2/ recipients
(similar results were observed by transplanting 13 107 unsorted bone marrow
cells). Organs of recipients were analyzed 6–10 weeks after transplant.
Functional Assays
For MCMV infection, mice were infected with 2.5 3 107 pfu i.p. To analyze
degranulation, bulk cells were stimulated with 5 ng/mL PMA and 50 ng/mL ion-
omycin, in the presence of Brefeldin A (Golgiplug, BD), monensin (Golgistop,BD), and anti-CD107a. To analyze cytokine production, cells were stimulated
with 5 ng/mL PMA and 50 ng/mL ionomycin, in the presence of Brefeldin A.
Adoptive Transfer Studies
Hepatic or medullary lymphocytes were isolated and depleted of T, B, granu-
locyte, and erythroid cell lineages with mAbs against CD4, CD5, CD8, CD19,
Gr-1, and Ter119 (Biolegend). Lineage cells were stained with mAbs against
CD3ε, CD49b (DX5), NK1.1, NKp46, and TRAIL. TRAIL+DX5 and TRAILDX5+
NK cells were sorted on a FACSAria II (BD). Purified TRAIL+ or DX5+ NK donor
cells were injected i.v. into separate, unirradiated Il2rg/Rag2/ recipients.
For transfer of hepatic TRAIL+ NK cells, 1 3 105 hepatic TRAIL+ NK cells or
1 3 105 hepatic DX5+ NK cells were transferred to recipient mice. The TRAIL+
NK cells for transfer were all hepatic. The DX5+ NK cells for transfer were 50%
splenic and 50% hepatic. For transfer of medullary TRAIL+ NK cells, at least
13 104 of the following FACS-purified, medullary NK cell subsets were trans-
ferred into immunodeficient recipients: TRAIL+CD27loCD11blo, TRAIL+
CD27hiCD11blo, DX5+CD27hiCD11blo, and DX5+CD27hi and loCD11bhi. Post-
sort purity of transferred cells was at least 93%.
Temporal Deletion Studies
Splenic (for Eomes deletion experiments) or hepatic (for T-bet deletion exper-
iments) lymphocytes were isolated and depleted of T, B, granulocyte, and
erythroid cell lineages. Lineage cells were stained with mAbs against
CD3ε, CD122, NK1.1, and NKp46. 13 106 NK cells were sorted on a FACSAria
II and washed thoroughly in serum-free medium prior to addition of TAT-Cre
(50 mg/mL) or medium alone (sham). NK cells were then incubated for
45 min at 37C. The reaction was quenched by adding media containing
20% FBS, followed by thorough washing. Treated or sham-treated donor cells
were injected intravenously into separate, unirradiated Il2rg/Rag2/ recip-
ients. For in vitro temporal deletion studies, splenic or hepatic lymphocytes
were isolated and depleted of T, B, granulocyte, and erythroid cell lineages,
but NK cells were not FACS purified prior to treatment with either TAT-Cre
or medium alone. 1 3 107 splenic or 1 3 106 hepatic lymphocytes entered
the TAT-Cre reaction. After the reaction was quenched and cells were
washed, they were cultured separately in 2,000 U/ml rIL-2 for 5 days. To
analyze function of acutely double-deficient NK cells in vitro, cells were stim-
ulated after 5 day culture with 5 PMA/ionomycin for 2 hr to purge preformed
granules and cytokines. Cells were then stimulated with 5 ng/mL PMA and
50 ng/mL ionomycin for 2 hr in the presence of Brefeldin A, monensin, and
anti-CD107a.
Quantitative RT-PCR
Splenic and hepatic lymphocytes were isolated and depleted of T, B, granulo-
cyte, and erythroid cell lineages. Lineage cells were stained with mAbs
against CD3ε, CD49b (DX5), NK1.1, NKp46, and TRAIL. TRAIL+ and DX5+
NK cells were sorted on a FACSAria II. RNA was isolated with the miRNeasy
kit (QIAGEN), and cDNA was synthesized with the SuperScript VILO cDNA
synthesis kit (Invitrogen). Q-PCR reactions were carried out with a TaqMan
7900HT machine and TaqMan gene expression assays (Applied Biosystems).
Relative amplification valueswere calculated by normalizing to amplification of
hypoxanthine guanine phosphoribosyl transferase (HPRT).
Statistical Analysis
Statistics were calculated with Prism software (GraphPad Software). To test
for significant differences in the number of NK cells between two groups of
adult mice, a Student’s t test with a two-tailed p value was performed. Differ-
ences in numbers of NK precursors among the four genotypes were analyzed
with a one-way ANOVA with a Tukey’s postcomparison test. Numbers
of neonatal NK cells among aged-matched wild-type and Tbx21/ mice
were analyzed with a paired t test. Statistical significance was reached at
p < 0.05.
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